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Purpose/Objective: The need for an accurate modeling and 
dosimetry of small radiation fields is mandatory for novel 
radiotherapy techniques. The standardization of the small 
field dosimetry is fundamental to ensure that different 
institutions deliver comparable and consistent radiation doses 
to their patients. In 2012 a project dedicated to stereotactic 
body radiotherapy (SBRT) dosimetric aspects has started in 
the framework of the Italian Association of Medical Physics 
(AIFM) SBRT working group. The current study presents 
measured MLC-defined small field output factors (OF) for the 
three major linear accelerator manufacturers and for 
different X-ray energies. 
Materials and Methods: A pre-questionnaire was sent to each 
center in order to evaluate specific differences in terms of 
the used methodology and detectors. Each center performed 
OF measurements by routine used detectors for field sizes 
ranging from 10×10 cm2 to 0.5×0.5 cm2, defined by both 
secondary jaws and MLC. Two set-up conditions were 
indicated: 10 cm depth in water phantom at SSD 90cm and 
SSD 100cm. The same measurements were repeated using the 
new PTW 60019 microDiamond detector. For fasting the 
measurements, two identical diamond were adopted. 
National Institute of Ionizing Radiation Metrology ENEA-INMRI 
carried out a complete characterization of the response of 
the two diamond dosimeters to ensure the equivalence of the 
detectors.  
Results: The project enrolled 30 Italian centers; micro-ion 
chambers were used for OF measurements in mostly of the 
centers (80%); in the remaining cases diode was used. For 
very small fields (≤ 1x1 cm2) OF have been measured with 
Gafchromic films in 10% of the cases and in one center with 
TLD detectors. 
In table are reported OF average values and standard 
deviations for 6 MV major linear accelerator manufacturers 
measured for each filed size by user detectors and 
microDiamond. The values in square brackets and 
parentheses beneath each field size value are average 
absolute percent differences between detectors results and 
the number of centers, respectively.  
 
 
 
Percentual differences between OF measured by user routine 
detector and microDiamond are showed in figure; results are 
less than 1% in most cases, even if for the field 1 cm x 1 cm 
differences reach significant values. 
 
 
 
Comparison between the two microDiamond detectors 
showed the equivalence of the devices with results fully 
agreeing with the technical specifications of the company. 
Conclusions: Results show that there is a relatively high 
degree of consistency regarding OF for Linac with the same 
model of the head. Differences between centers decrease 
with PTW-60019, in particular for very small fields. The 
agreement between microDiamond and user detector 
measurements confirms PTW-60019 detector as a candidate 
for small field clinical radiation dosimetry in advanced 
radiation therapy techniques. 
   
OC-0154   
UK SABR Consortium Lung Dosimetry Audit; relative 
dosimetry results 
J. Lee1, H.M.O. Mayles1, C.R. Baker1, S.M. Jafari2, G. 
Distefano3, C.H. Clark3 
1The Clatterbridge Cancer Centre - Wirral NHS Foundation 
Trust, Physics, Bebington Wirral, United Kingdom  
2University of Surrey, Department of Physics, Guildford, 
United Kingdom 
3Royal Surrey County Hospital NHS Trust, Physics, Guildford, 
United Kingdom  
 
Purpose/Objective: The UK SABR Consortium QA group 
conducted a postal dosimetry audit of SABR lung plans at 21 
UK centres. The purpose of this was to verify the accuracy of 
calculated dose distributions, improve confidence of centres 
in the early stages of implementing lung SABR and to 
establish a benchmark QA method. Here the results of the 
GafChromic film relative dosimetry arm of the audit are 
given. 
Materials and Methods: Individual centres were asked to plan 
a treatment to a pre-defined PTV in the CIRS Thorax 
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phantom, using their clinical method and prescription dose. 
EBT3 GafChromic film was used to measure an axial plane of 
dose. Pins in the phantom facilitated alignment of the film 
and calculated dose planes. Gantry linac and Cyberknife 
centres were audited, using a variety of TPS with pencil 
beam, AAA, CCC, Acuros and Monte Carlo algorithms. 
Scanned films were compared to dose distributions calculated 
by the individual centres, using single red-channel dosimetry 
and a purpose-built Matlab application. Centres were also 
asked to irradiate additional calibration films to provide 
output-normalised optical density to dose calibration.  
Measured and calculated isodoses corresponding to 120, 100, 
70 and 50% of prescription dose were compared (figure 1), 
and conformity and maximum distance to agreement were 
measured. For the areas bound by the 100, 50 and 30% 
calculated isodoses, local gamma analysis, mean gamma and 
gamma pass rate (at 3%, 2mm) and a mean dose comparison 
was performed. The latter was compared to the alanine 
dosimetry results. 
Results: The dosimetry of the calibration films was 
reproducible to ±0.9% (1.S.D), for doses ranging from 4.3 to 
26.9 Gy. 
The audit relative dosimetry results are reported in table 1. 
Mean dose differences within the 100% calculated isodose 
line agreed well with alanine dosimetry; -0.1 ± 2.0 % (1.S.D). 
Gamma pass rates (%) and mean gamma results varied with 
some outlying measurements, mostly caused by small dose 
deviations within the PTV or at low doses. Isodose line 
agreement (figure 1) was generally much closer at the 70 and 
100% dose levels, indicated by the lower S.D. (table 1, 
column 5). The exception was the centre using a pencil beam 
algorithm, where the measured prescription dose covered a 
significantly smaller area than that calculated, consistent 
with the algorithm’s known limitations calculating dose in 
low density lung surrounding tumour.  
 
 
 
 
 
 
Conclusions: Of the 21 UK centres audited, 74% of 
measurements were within ±3% agreement compared to 
calculated doses. Where appropriate, outlying centres have 
been offered support from the QA Group to bring their results 
into line.  
The EBT3 GafChromic film was found to be highly suited to a 
postal audit, reliably giving detailed information about the 
geometric and dosimetric accuracy of treatment. 
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Purpose/Objective: The UK SABR Lung Consortium dose audit 
was designed to assess the positional and dosimetric accuracy 
of SABR lung treatment delivery. The audit has been carried 
out in 21 radiotherapy centres between October 2013 and 
July 2014 in order to provide an independent check of safe 
implementation and to identify problems in the modelling 
and delivery of SABR lung treatment. 
Materials and Methods: A mail based audit using EBT3 
GafChromic film and alanine dosimeters was designed. A CIRS 
Model 002LFC anthropomorphic thorax phantom which 
contained 9 adjacent alanine pellets in the tip of a Farmer 
chamber shaped insert was scanned, structure sets for the 
ITV and alanine pellets were pre-delineated, and was sent to 
radiotherapy centres to be loaded into their treatment 
planning system. Each centre used this CT scan set to create 
a SABR plan using their current planning protocol (including 
dose, fractionation and coverage) and technique. The centres 
used their own margin to create the PTV. A range of delivery 
techniques were used including conformal, VMAT and 
Cyberknife and calculated using local algorithms (AAA, 
Collapsed Cone, Monte Carlo and Pencil beam). The doses 
determined by the alanine dosimeters were compared to 
expected doses determined by treatment plan system (TPS) 
calculation, film and local ionisation chamber measurements. 
Results: The mean % difference between the alanine 
measured doses, the TPS calculated doses, and the local 
chamber measurements found to be within 2% (1 SD) as given 
in table 1. As shown, alanine findings were supported by the 
film results.  
 
There was no significant difference between the performance 
of AAA and Monte Carlo algorithms (mean difference of 0.2% 
(+/- 1.3) versus 0.4% (+/- 2.1)), while a mean difference of 
1.4 % (+/- 1.0) was seen when the collapsed cone algorithms 
were used. The pencil beam algorithm significantly 
overestimated the dose (-5.04%).  
Across all algorithms, the mean differences in regards to 
delivery techniques varied by 0.6% (+/- 1) and -0.1% (+/- 1.5) 
using Conformal and VMAT respectively. The results for the 
Cyberknife delivery technique were at either end of 
distribution curve, with the pencil beam overestimating the 
dose and the Monte Carlo algorithm making a slight 
underestimation (figure 1). 
